tiprankstipranks
Neurocrine (NBIX)
NASDAQ:NBIX

Neurocrine (NBIX) Balance Sheet

1,140 Followers

Neurocrine Balance Sheet

Neurocrine's total assets for Q4 2023 were $3.25B, an increase of 14.16% from the previous quarter. NBIX total liabilities were $1.02B for the fiscal quarter, a 20.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 3.25B$ 2.37B$ 2.07B$ 1.73B$ 1.31B
Total Liabilities
$ 1.02B$ 660.90M$ 698.50M$ 608.50M$ 669.10M
Total Equity Gross Minority
$ 2.23B$ 1.71B$ 1.37B$ 1.13B$ 636.90M
Total Capitalization
$ 2.49B$ 1.71B$ 2.09B$ 1.44B$ 636.90M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 94.40M$ 86.70M
Currency in USD

Neurocrine Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis